Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Hospitals and Health Care
nuroflux is a Hospitals and Health Care brand in Sydney, NSW. Privately held, at nuroflux.com. It holds one address on record, all in Australia. It employs 5 people, on the record. It lists digital health, medical device and neurology among its specialties. One Australian registration (ABN) is a confirmed match. Its latest round on record is Seed, US$75.0K. It is listed alongside seven similar brands, mostly in Medical Equipment Manufacturing.
ABN94644154745
| NUROFLUX PTY LTD | ABN 94644154745 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Nuroflux has developed a wearable medical device for the non-invasive, continuous monitoring of cerebral blood flow via a patent-protected, ECG-based measurement known as electrocardiography brain perfusion index (EBPi).
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 2 |
|---|---|
| Axis | 2022 to 2026 |
| Seed · 6 Jun 2022 | US$ 75.0K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One New South Wales entity on the ABR: NUROFLUX PTY LTD (ABN 94 644 154 745), high confidence.
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Sydney, NSW.
Two rounds. Latest 6 June 2022: Seed, US$75,000, investor Remarkable.
Five tags on the brand's own list, among them digital health, medical device and neurology.
8 profiles list nuroflux as a peer — 85th percentile in Hospitals and Health Care. It lists ten peers of its own. VueMotion and M&T Biotech list it back.